SELECT id, `name`, primary_key, `key`, treemapgroup, name_cn, zacks_table_name, compare_key, compare_display_name from gurufocu_main.financial_definition where termpagedisplay=1 and `key` = 'pocf' CNMD (Conmed) Price-to-Operating-Cash-Flow
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (NYSE:CNMD) » Definitions » Price-to-Operating-Cash-Flow

Conmed (Conmed) Price-to-Operating-Cash-Flow

: 18.33 (As of Today)
View and export this data going back to 1987. Start your Free Trial

As of today (2024-04-23), Conmed's share price is $72.61. Conmed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.96. Hence, Conmed's Price-to-Operating-Cash-Flow Ratio for today is 18.33.

The historical rank and industry rank for Conmed's Price-to-Operating-Cash-Flow or its related term are showing as below:

CNMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.41   Med: 28.46   Max: 141.59
Current: 18.3

During the past 13 years, Conmed's highest Price-to-Operating-Cash-Flow Ratio was 141.59. The lowest was 9.41. And the median was 28.46.

CNMD's Price-to-Operating-Cash-Flow is ranked better than
56.29% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 20.4 vs CNMD: 18.30

Conmed's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $1.79. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.96.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Conmed was 257.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 22.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -1.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 1.60% per year.

During the past 13 years, Conmed's highest 3-Year average Operating Cash Flow per Share Growth Rate was 73.40% per year. The lowest was -29.90% per year. And the median was 6.00% per year.

Conmed Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Conmed's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.68 51.14 40.86 79.78 27.56

Conmed Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.78 108.41 116.34 56.28 27.56
Competitive Comparison

For the Medical Devices subindustry, Conmed's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Conmed Price-to-Operating-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Conmed's Price-to-Operating-Cash-Flow falls into.


Conmed Price-to-Operating-Cash-Flow Calculation

Conmed's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=72.61/3.962
=18.33

Conmed's Share Price of today is $72.61.
Conmed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.96.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Conmed Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Conmed's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Conmed (Conmed) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (NYSE:CNMD) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
TMDX PRCT TNDM IART NARI UFPT LIVN RXST ATEC INMD TSE:5212 ABT SYK MDT BSX EW DXCM SZSE:300760 ZBH ALGN
Traded in Other Exchanges
EC8:Germany
Address
11311 Concept Boulevard, Largo, FL, USA, 33773
Website
https://www.conmed.com
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Executives
Peters Stanley W Iii officer: VP GM General Surgery C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Todd W. Garner officer: Executive Vice President & CFO C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Edward A. Clifford officer: VP Global Manufacturing C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Curt R Hartman director C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John D. Ferrell officer: Executive Vice President - HR C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Brian Concannon director HAEMONETICS CORP, 400 WOOD RD, BRAINTREE MA 02184-9144
Peter K Shagory officer: EVP,STRAT & CORP DEVT C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Daniel Jonas officer: Vice President/Legal Affairs, other: General Counsel C/O CONMED CORP, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Terence M Berge officer: VP Corp. Treasurer C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Johonna Marie Pelletier officer: Treasurer and VP, Tax C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Jerome J. Lande director 1 WORLD TRADE CENTER, 85TH FLOOR, NEW YORK NY 10007
Brent Lalomia officer: Vice President QA and RA C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John Jed Kennedy officer: VP GM GI C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Mark E Tryniski director C/O CONMED CORP., 11311 CONCEPT BOULEVARD, LARGO FL 33773
Pat Beyer officer: President-Conmed International C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773